OUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIENTS INCLUDED IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA. (12th June 2019) - Gac, A.; Chartier, L.; Girinsky, T.; Gotti, M.; Lazarovici, J.; Aurer, I.; Musto, P.; Damaj, G.; Federico, M.; Fortpied, C.; Raemaekers, J.; Meignan, M.; et al.